Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 5 | Journal of Translational Medicine

Figure 5

From: Administered circulating microparticles derived from lung cancer patients markedly improved angiogenesis, blood flow and ischemic recovery in rat critical limb ischemia

Figure 5

Immunofluorescence (IF) microscope (400×) findings of stromal cell-derived factor (SDF)- + and CXCR4 + stained cells in ischemic quadriceps by day 14 following CLI procedure (n =  8). A to E) Showing the IF stain of SDF-1α+ cells (white arrows) in five groups. F) * vs. other groups with different symbols (*, †, ‡, §), p < 0.0001. G to K) Illustrating the IF stain of CXCR4+ cells (white arrows) in five groups. L) * vs. other groups with different symbols (*, †, ‡, §), p < 0.0001. Scale bars in right lower corner represent 20 μm. All statistical analyses were performed by one-way ANOVA, followed by Bonferroni multiple comparison post hoc test. Symbols (*, †, ‡, §) indicate significance (at 0.05 level). SC = sham control; CLI = critical limb ischemia; Lc-MPs = lung-cancer patient-derived microparticles; Hs-MPs = Healthy subject-derived microparticles.

Back to article page